Cargando…
Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis
BACKGROUND: It has been postulated that patient’s sex impacts response to immunotherapy. Sex modulation of immunotherapy benefit, however, has not yet been explored using patient-level data, where potential confounders, as well as histologic type, can be accounted for. Here we investigated the assoc...
Autores principales: | Tuminello, Stephanie, Alpert, Naomi, Veluswamy, Rajwanth R., Kumar, Arvind, Gomez, Jorge E., Flores, Raja, Taioli, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767728/ https://www.ncbi.nlm.nih.gov/pubmed/35045806 http://dx.doi.org/10.1186/s12885-022-09187-y |
Ejemplares similares
-
PD-L1 as a prognostic biomarker in surgically resectable non-small cell lung cancer: a meta-analysis
por: Tuminello, Stephanie, et al.
Publicado: (2020) -
3363 Prognostic Value of Immune-Related Biomarkers in Resected Non-Small Cell Lung Cancer
por: Veluswamy, Rajwanth R, et al.
Publicado: (2019) -
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
por: Tuminello, Stephanie, et al.
Publicado: (2019) -
Association of Personal Characteristics and Effectiveness of Immunotherapy in Late-Stage Non-Small Cell Lung Cancer: A Systematic Review
por: Patel, Krishna, et al.
Publicado: (2022) -
Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer
por: Patel, Krishna H., et al.
Publicado: (2023)